Biofermin Pharmaceutical Co., Ltd.

Calculating rank

USPTO Granted Patents = 4

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 1

Loading Chart...

10 inventors (with patents filed for the assignee):

Masaki Shimakawa (4 out of 4 patents)

Hiroshi Ohno (4 out of 34 patents)

Yoshiki Tanaka (2 out of 2 patents)

4. Ayako Maeda (1 out of 1 patent)

5. Tomohiro Kawahara (1 out of 1 patent)

6. Takaomi Kessoku (1 out of 3 patents)

7. Atsushi Nakajima (1 out of 6 patents)

8. Yosuke Oikawa (1 out of 1 patent)

9. Yasuhiro Isa (1 out of 1 patent)

10. Hideki Yamamura (1 out of 1 patent)

11. Kouichi Hirayama (0 patent)

12. Taiji Mizuguchi (0 patent)

13. Teruhiko Arai (0 patent)

14. Atsushi Nakajima (0 patent)

15. Taiji c/o Biofermin Pharma Co Ltd Mizuguchi (0 patent)

4 patents: Sort by Forward Citations

1. 11376287 - Agent acting on transcellular ion transporter in intestinal tract, agent for activating chloride channel, agent for preventing or treating renal disease, or agent for promoting defecation (2022-07-05),

2. 11224622 - Agent for preventing or treating fat-associated diseases and/or inflammation (2022-01-18),

3. 11219650 - Agent for preventing or treating small intestinal injury induced by specific NSAID and PPI (2022-01-11),

4. 8889375 - Hypoglycemic effect enhancer (2014-11-18),

Company Overview

Biofermin Pharmaceutical Co., Ltd. is a leading pharmaceutical company specializing in the research, development, and production of innovative medicines and healthcare products. With a focus on improving patient outcomes and quality of life, Biofermin is committed to excellence in the pharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#51 in Kobe

#7,590 in Japan

Kobe, Japan

Biofermin Pharmaceutical Co., Ltd.

Forward Citations = 1

10 inventors:

Masaki Shimakawa (4 out of 4 patents)

Hiroshi Ohno (4 out of 34 patents)

Yoshiki Tanaka (2 out of 2 patents)

4. Ayako Maeda (1 out of 1 patent)

5. Tomohiro Kawahara (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biofermin Pharmaceutical Co., Ltd.. Retrieved from https://idiyas.com/company/biofermin-pharmaceutical-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]